In cancer studies, the luciferase gene linked to the MPC promoter demonstrated that the chicken ovalbumin upstream promoter-transcription factor II (COUP-TFII) represses MPC1 expression in prostate cancer cells, leading to a metabolic switch toward increased glycolysis and promotes cancer progression (37). This evidence concerns the gene MPC1 and prostate carcinoma.